Co-Authors
This is a "connection" page, showing publications co-authored by Jane O'Halloran and Ali Ellebedy.
Connection Strength
1.241
-
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants. Immunity. 2021 09 14; 54(9):2159-2166.e6.
Score: 0.241
-
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 08; 596(7870):109-113.
Score: 0.238
-
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021 07; 595(7867):421-425.
Score: 0.237
-
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020 12; 6(50).
Score: 0.229
-
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study. Ann Intern Med. 2021 11; 174(11):1572-1585.
Score: 0.060
-
Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J Immunol. 2021 09 01; 207(5):1229-1238.
Score: 0.060
-
Assessment of serological assays for identifying high titer convalescent plasma. Transfusion. 2021 09; 61(9):2658-2667.
Score: 0.060
-
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
Score: 0.058
-
SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response. Front Immunol. 2020; 11:618402.
Score: 0.058